Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

This study has been completed.

Study NCT00046371 Information provided by Oncothyreon Canada Inc.

First Received: September 27, 2002 Last Updated: January 22, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2005
Estimated Primary Completion Date:	No date given